High Levels of N-Palmitoylethanolamide and N-Stearoylethanolamide in Microdialysate Samples from Myalgic Trapezius Muscle in Women

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Ghafouri, Nazdar ^a,b   Ghafouri, Bijar ^a   Larsson, Britt ^a   Turkina, Maria V ^a   Karlsson, Linn ^a   Fowler, Christopher J ^b   Gerdle, Björn ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ICOSANOID; PALMIDROL; STEAROYLETHANOLAMIDE; UNCLASSIFIED DRUG; DIALYSIS FLUID; PALMITIC ACID DERIVATIVE; STEARIC ACID DERIVATIVE;

ADULT; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DIALYSATE; FATTY ACID ANALYSIS; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MICRODIALYSIS; MUSCLE LEVEL; MYALGIA; NANOANALYSIS; NECK PAIN; NOCICEPTION; PAIN ASSESSMENT; SHOULDER PAIN; TANDEM MASS SPECTROMETRY; TRAPEZIUS MUSCLE; WOMEN'S HEALTH; CHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; MUSCLE DISEASE; NANOTECHNOLOGY; PATHOLOGY; SKELETAL MUSCLE;

ADULT; CHROMATOGRAPHY, LIQUID; CHRONIC PAIN; DIALYSIS SOLUTIONS; FEMALE; HUMANS; MICRODIALYSIS; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; NANOTECHNOLOGY; NECK PAIN; PALMITIC ACIDS; SHOULDER PAIN; STEARIC ACIDS; TANDEM MASS SPECTROMETRY;

EID: 84859239736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027257     Document Type: Article

References (44)

1. Lidgren L, (2008) Preface: Neck pain and the decade of the Bone and Joint 2000-2010. Spine 33: S1-S2.
2. Engel GL, (1977) The need for a new medical model: A challenge for biomedicine. Science 196: 129-136.
3. Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC, (2007) The Biopsychosocial Approach to Chronic Pain: Scientific Advances and Future Directions. Psychological Bulletin 133: 581-624.
4. Börsbo B, Peolsson M, Gerdle B, (2008) Catastrophizing, depression, and pain: Correlation with and influence on quality of life and health - A study of chronic whiplash-associated disorders. J Rehabil Med 40: 562-569.
5. Ocañez KLS, Kathryn McHugh R, Otto MW, (2010) A meta-analytic review of the association between anxiety sensitivity and pain. Depression and Anxiety 27: 760-767.
6. Asmundson GJG, Katz J, (2009) Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art. Depress Anxiety 26: 888-901.
7. Dersh J, Gatchel RJ, Polatin P, (2001) Chronic spinal disorders and psychopathology: research findings and theoretical considerations. The Spine Journal 1: 88-94.
8. Means-Christensen AJ, Roy-Byrne PP, Sherbourne CD, Craske MG, Stein MB, (2008) Relationships among pain, anxiety, and depression in primary care. Depression & Anxiety (1091-4269) 25: 593-600.
9. Gerdle B, Lemming D, Kristiansen J, Larsson B, Peolsson M, et al.(2008) Biochemical alterations in the trapezius muscle of patients with chronic whiplash associated disorders (WAD)- A microdialysis study. European Journal of Pain 12: 82-93.
10. Schneider GM, Smith AD, Hooper A, Stratford P, Schneider KJ, et al.(2010) Minimizing the source of nociception and its concurrent effect on sensory hypersensitivity: An exploratory study in chronic whiplash patients. BMC Musculoskelet Disord 11: 29.
11. Staud R, Nagel S, Robinson ME, Price DD, (2009) Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain 145: 96-104.
12. Coutaux A, Adam F, Willer JC, Le Bars D, (2005) Hyperalgesia and allodynia: peripheral mechanisms. Joint Bone Spine 72: 359-371.
13. Ungerstedt U, Hallstrom A, (1987) In vivo microdialysis-a new approach to the analysis of neurotransmitters in the brain. Life Sci 41: 861-864.
14. Langley CK, Aziz Q, Bountra C, Gordon N, Hawkins P, et al.(2008) Volunteer studies in pain research-opportunities and challenges to replace animal experiments: the report and recommendations of a Focus on Alternatives workshop. Neuroimage 42: 467-473.
15. Rosendal L, Larsson B, Kristiansen J, Peolsson M, Sogaard K, et al.(2004) Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercise. Pain 112: 324-334.
16. Larsson B, Rosendal L, Kristiansen J, Sjogaard G, Sogaard K, et al.(2008) Responses of algesic and metabolic substances to 8 h of repetitive manual work in myalgic human trapezius muscle. Pain 140: 479-490.
17. Ernberg M, Hedenberg-Magnusson B, Alstergren P, Kopp S, (1999) The level of serotonin in the superficial masseter muscle in relation to local pain and allodynia. Life Sci 65: 313-325.
18. Pacher P, Batkai S, Kunos G, (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58: 389-462.
19. Calignano A, La Rana G, Giuffrida A, Piomelli D, (1998) Control of pain initiation by endogenous cannabinoids. Nature 394: 277-281.
20. Jaggar SI, Hasnie FS, Sellaturay S, Rice AS, (1998) The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76: 189-199.
21. D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, et al.(2009) Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-κB nuclear signalling in dorsal root ganglia. Eur J Pharmacol 613: 54-59.
22. Farquhar-Smith W, Jaggar S, Rice A, (2002) Attenuation of nerve growth factor- induced visceral hyperalgesia via cannabinoid CB1 and CB2-like receptors. Pain 97: 11-21.
23. LoVerme J, Russo R, La Rana G, Fu J, Farthing J, et al.(2006) Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther 319: 1051-1061.
24. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, et al.(2005) The nuclear receptor peroxisome proliferator-activated receptor alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67: 15-19.
25. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, et al.(2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425: 90-93.
26. Kuorinka I, Jonsson B, Kilbom A, Vinterberg H, Biering-Sörensen F, et al.(1987) Standardised Nordic questionnaires for the analysis of musculoskeletal symptoms. Appl Ergon 18.3: 233-237.
27. Ohlsson K, Attewell RG, Johnsson B, Ahlm A, Skerfving S, (1994) An assessment of neck and upper extrimity disorders by questionnaire and clinical examination. Ergonomics 37: 891-897.
28. Plock N, Kloft C, (2005) Microdialysis-theoretical background and recent implementation in applied life-sciences. Eur J Pharm Sci 25: 1-24.
29. Scheller D, Kolb J, (1991) The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialysate samples. J Neurosci Methods 40: 31-38.
30. Buczynski M, Parsons LH, (2010) Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls. British Journal of Pharmacology 160: 423-442.
31. Rosendal L, Kristiansen J, Gerdle B, Sogaard K, Peolsson M, et al.(2005) Increased levels of interstitial potassium but normal levels of muscle IL-6 and LDH in patients with trapezius myalgia. Pain 119: 201-209.
32. Gerdle B, Hilgenfeldt U, Larsson B, Kristiansen J, Sogaard K, et al.(2008) Bradykinin and kallidin levels in the trapezius muscle in patients with work-related trapezius myalgia, in patients with whiplash associated pain, and in healthy controls- A microdialysis study of women. Pain 139: 578-587.
33. Sjogaard G, Rosendal L, Kristiansen J, Blangsted AK, Skotte J, et al.(2010) Muscle oxygenation and glycolysis in females with trapezius myalgia during stress and repetitive work using microdialysis and NIRS. Eur J Appl Physiol 108: 657-669.
34. Flodgren GM, Crenshaw AG, Alfredson H, Fahlstrom M, Hellstrom FB, et al.(2005) Glutamate and prostaglandin E2 in the trapezius muscle of female subjects with chronic muscle pain and controls determined by microdialysis. Eur J Pain 9: 511-515.
35. Shah JP, Phillips TM, Danoff JV, Gerber LH, (2005) An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol 99: 1977-1984.
36. Gerdle B, Söderberg K, Salvador Puigvert L, Rosendal L, Larsson B, (2010) Increased Interstitial Concentrations of Pyruvate and Lactate in the Trapezius Muscle of Patients with Fibromyalgia- a Microdialysis Study of the Trapezius Muscle. J Rehab Med 42: 679-687.
37. Movahed P, Jonsson BA, Birnir B, Wingstrand JA, Jorgensen TD, et al.(2005) Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. J Biol Chem 280: 38496-38504.
38. Dalle Carbonare M, Del Giudice E, Stecca A, Colavito D, Fabris M, et al.(2008) A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story. J Neuroendocrinol 20: 26-34.
39. Gibson W, Arendt-Nielsen L, Graven-Nielsen T, (2006) Referred pain and hyperalgesia in human tendon and muscle belly tissue. Pain 120: 113-123.
40. Graven-Nielsen T, Arendt-Nielsen L, Svensson P, Jensen TS, (1997) Quantification of local and referred muscle pain in humans after sequential i.m. injections of hypertonic saline. Pain 69: 111-117.
41. Costa B, Comelli F, Bettoni I, Colleoni M, Giagnoni G, (2008) The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors. Pain 139: 541-550.
42. Hula N, Chumak A, Berdyshev A, Mehed' O, Horid'ko T, et al.(2009) [Anti-inflammatory effect of N-stearoylethanolamine in experimental burn injury in rats]. Ukr Biokhim Zh Ukrainian 81: 107-116.
43. Solorzano C, Zhu C, Battista N, Astarita G, Lodola A, et al.(2009) Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc Natl Acad Sci U S A 106: 20966-20971.
44. Fowler CJ, Naidu PS, Lichtman A, Onnis V, (2009) The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1. Br J Pharmacol 156: 412-419.